Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2008 1
2009 1
2010 2
2011 2
2012 4
2013 3
2014 2
2016 1
2017 1
2018 1
2019 6
2020 3
2021 6
2022 10
2023 7
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

48 results

Results by year

Filters applied: . Clear all
Page 1
Prostate Cancer Screening with PSA and MRI Followed by Targeted Biopsy Only.
Hugosson J, Månsson M, Wallström J, Axcrona U, Carlsson SV, Egevad L, Geterud K, Khatami A, Kohestani K, Pihl CG, Socratous A, Stranne J, Godtman RA, Hellström M; GÖTEBORG-2 Trial Investigators. Hugosson J, et al. N Engl J Med. 2022 Dec 8;387(23):2126-2137. doi: 10.1056/NEJMoa2209454. N Engl J Med. 2022. PMID: 36477032 Free PMC article. Clinical Trial.
Unanswered questions in prostate cancer - findings of an international multi-stakeholder consensus by the PIONEER consortium.
Omar MI, MacLennan S, Ribal MJ, Roobol MJ, Dimitropoulos K, van den Broeck T, MacLennan SJ, Axelsson SE, Gandaglia G, Willemse PP, Mastris K, Ransohoff JB, Devecseri Z, Abbott T, De Meulder B, Bjartell A, Asiimwe A, N'Dow J; PIONEER Consortium. Omar MI, et al. Nat Rev Urol. 2023 Aug;20(8):494-501. doi: 10.1038/s41585-023-00748-9. Epub 2023 Apr 3. Nat Rev Urol. 2023. PMID: 37012441 Review.
Osteoclasts directly influence castration-resistant prostate cancer cells.
Huang J, Freyhult E, Buckland R, Josefsson A, Damber JE, Welén K. Huang J, et al. Among authors: josefsson a. Clin Exp Metastasis. 2022 Oct;39(5):801-814. doi: 10.1007/s10585-022-10179-2. Epub 2022 Aug 16. Clin Exp Metastasis. 2022. PMID: 35971022 Free PMC article.
Introducing PIONEER: a project to harness big data in prostate cancer research.
Omar MI, Roobol MJ, Ribal MJ, Abbott T, Agapow PM, Araujo S, Asiimwe A, Auffray C, Balaur I, Beyer K, Bernini C, Bjartell A, Briganti A, Butler-Ransohoff JE, Campi R, Cavelaars M, De Meulder B, Devecseri Z, Voss MD, Dimitropoulos K, Evans-Axelsson S, Franks B, Fullwood L, Horgan D, Smith EJ, Kiran A, Kivinummi K, Lambrecht M, Lancet D, Lindgren P, MacLennan S, MacLennan S, Nogueira MM, Moen F, Moinat M, Papineni K, Reich C, Reiche K, Rogiers S, Sartini C, van Bochove K, van Diggelen F, Van Hemelrijck M, Van Poppel H, Zong J, N'Dow J; PIONEER Consortium. Omar MI, et al. Nat Rev Urol. 2020 Jun;17(6):351-362. doi: 10.1038/s41585-020-0324-x. Epub 2020 May 27. Nat Rev Urol. 2020. PMID: 32461687 Review.
Clinical and biological relevance of the transcriptomic-based prostate cancer metastasis subtypes MetA-C.
Thysell E, Köhn L, Semenas J, Järemo H, Freyhult E, Lundholm M, Thellenberg Karlsson C, Damber JE, Widmark A, Crnalic S, Josefsson A, Welén K, Nilsson RJA, Bergh A, Wikström P. Thysell E, et al. Among authors: josefsson a. Mol Oncol. 2022 Feb;16(4):846-859. doi: 10.1002/1878-0261.13158. Epub 2021 Dec 27. Mol Oncol. 2022. PMID: 34889043 Free PMC article.
The Study of Active Monitoring in Sweden (SAMS): a randomized study comparing two different follow-up schedules for active surveillance of low-risk prostate cancer.
Bratt O, Carlsson S, Holmberg E, Holmberg L, Johansson E, Josefsson A, Nilsson A, Nyberg M, Robinsson D, Sandberg J, Sandblom D, Stattin P. Bratt O, et al. Among authors: josefsson a. Scand J Urol. 2013 Oct;47(5):347-55. doi: 10.3109/21681805.2013.813962. Epub 2013 Jul 24. Scand J Urol. 2013. PMID: 23883427 Free PMC article. Review.
48 results